Changes in Hematologic Parameters during Treatment with Medroxyprogesterone Acetate for Breast Cancer

This publication has 22 references indexed in Scilit:

• Vascular toxicity associated with antineoplastic agents.
  Journal of Clinical Oncology, 1986
• Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer
  Breast Cancer Research and Treatment, 1985
• Activation of blood coagulation in cancer: Trousseau's syndrome revisited.
  1983
• Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma
  Archiv für Gynäkologie, 1981
• Experimental Study on the Anabolic and Androgenic/Antiandrogenic Activity of Different Dose Levels of Medroxyprogesterone Acetate (MAP) in Rats
  Oncology, 1981
• TROUSSEAUʼS SYNDROME AND OTHER MANIFESTATIONS OF CHRONIC DISSEMINATED COAGULOPATHY IN PATIENTS WITH NEOPLASMS
  Medicine, 1977
• Progestational agents and blood coagulation
  American Journal of Obstetrics and Gynecology, 1972
• Blood Clotting and Platelet Aggregation during Oral Progestogen Contraception: A Follow-up Study
  BMJ, 1971
• COAGULATION AND FIBRINOLYTIC STUDIES DURING CONTINUOUS USE OF LOW DOSE GESTAGEN
  Acta Endocrinologica, 1970
• VENOUS THROMBOHMBOLIC DISEASE AND THE USE OF ORAL CONTRACEPTIVES: A Review of Mortality Statistics in England and Wales
  The Lancet, 1968